Peter Boyle
Impact in
- Urology top 0.01%
- Urinary Bladder and Prostate Research
- Otorhinolaryngology top 0.05%
- Head and Neck Cancer Studies
Papers in
- Oncology 184
- Cancer Risks and Factors 79
- Global Cancer Incidence and Screening 78
- Colorectal Cancer Screening and Detection 29
-
- Prostate Cancer Diagnosis and Treatment 44
- Co-authors
- Patrick Maisonneuve (74 shared papers)Jacques Ferlay (5 shared papers)Mathieu Boniol (36 shared papers)Philippe Autier (44 shared papers)Carlo La Vecchia (81 shared papers)Silvia Franceschi (31 shared papers)Sara Gandini (16 shared papers)Eva Negri (57 shared papers)
- Journals
- International Journal of Cancer (41 papers)European Journal of Cancer (30 papers)Cancer Causes & Control (23 papers)Annals of Oncology (23 papers)British Journal of Urology (19 papers)
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Peter Boyle
619 papers receiving 40.9k citations
Peter Boyle's Hit Papers
Peers
Comparison fields: 5 of 219
- Urology 4.4k
- Otorhinolaryngology 2.3k
- Oncology 11.0k
- Cancer Research 3.9k
- Periodontics 1.1k
Countries citing papers authored by Peter Boyle
This map shows the geographic impact of Peter Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Boyle more than expected).
Fields of papers citing papers by Peter Boyle
This network shows the impact of papers produced by Peter Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Boyle. The network helps show where Peter Boyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Boyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 630 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Estimates of the cancer incidence and mortality in Europe in 2006 Hit paper breakdown → | 2007 | 3158 |
| 2 | Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review Hit paper breakdown → | 2005 | 1694 |
| 3 | Cancer incidence and mortality in Europe, 2004 Hit paper breakdown → | 2005 | 983 |
| 4 | Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure Hit paper breakdown → | 2004 | 959 |
| 5 | Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7) Hit paper breakdown → | 2003 | 910 |
| 6 | Cancer incidence and mortality in Europe Hit paper breakdown → | 1989 | 810 |
| 7 | Overview of the main outcomes in breast-cancer prevention trials Hit paper breakdown → | 2003 | 739 |
| 8 | Development and Validation of a Food Frequency Questionnaire in Spain Hit paper breakdown → | 1993 | 718 |
| 9 | Tobacco smoking and cancer: A meta‐analysis Hit paper breakdown → | 2007 | 707 |
| 10 | Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Hit paper breakdown → | 1999 | 690 |
| 11 | Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women Hit paper breakdown → | 1998 | 625 |
| 12 | Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi Hit paper breakdown → | 2004 | 604 |
| 13 | Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia Hit paper breakdown → | 2002 | 591 |
| 14 | Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors Hit paper breakdown → | 2005 | 548 |
| 15 | Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study Hit paper breakdown → | 2001 | 506 |
| 16 | Triple-negative breast cancer: epidemiological considerations and recommendations Hit paper breakdown → | 2012 | 473 |
| 17 | Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis Hit paper breakdown → | 2012 | 462 |
| 18 | 2005 | 431 | |
| 19 | 2003 | 376 | |
| 20 | 2002 | 373 |
About Peter Boyle
Peter Boyle is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health, Surgery and Molecular Biology, having authored 630 papers that have together received 43.5k indexed citations. Recurring topics across this work include Cancer Risks and Factors (79 papers), Global Cancer Incidence and Screening (78 papers), Prostate Cancer Diagnosis and Treatment (44 papers), Urinary Bladder and Prostate Research (41 papers), Nutritional Studies and Diet (37 papers), Head and Neck Cancer Studies (29 papers), Colorectal Cancer Screening and Detection (29 papers) and Lymphoma Diagnosis and Treatment (21 papers). The work is most often cited by research in Urology (4.4k citations), Otorhinolaryngology (2.3k citations), Oncology (11.0k citations), Cancer Research (3.9k citations) and Periodontics (1.1k citations). Peter Boyle has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Patrick Maisonneuve, Jacques Ferlay, Mathieu Boniol, Philippe Autier, Carlo La Vecchia, Silvia Franceschi, Sara Gandini, Eva Negri, Chris Robertson and Murielle Colombet. Their work appears in journals such as International Journal of Cancer, European Journal of Cancer, Cancer Causes & Control, Annals of Oncology and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.